Quality of life progression after parathyroidectomy
OtherStudy the progression of quality of life
NCT Number: NCT07151664
The purpose of this study is to characterize changes in quality of life in patients who had undergone parathyroidectomy for secondary hyperparathyroidism due to end-stage renal disease, based on data extracted from an established database
Trial opening soon.
Get Notified18 year and older
All sexes
Observational
Data were retrospectively collected from an established database of patients who underwent surgery for renal secondary hyperparathyroidism (SHPT). Extracted information included demographic and clinical characteristics (age, gender, education level, clinical symptoms), baseline quality of life assessed by the 36-item Short-Form Health Survey (SF-36), and completed follow-up assessments of SF-36 scores, depression, and anxiety at one, three, six months, and one year postoperatively.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Age ≥18 years; Patients who had undergone parathyroidectomy for secondary hyperparathyroidism due to end-stage renal disease.
Exclusion criteria
Patients who underwent kidney transplantation during the study period. Patients with postoperative whole blood parathyroid hormone levels >300 pg/mL within the first week after surgery.
Patients with missing postoperative quality of life assessment data.
Study the progression of quality of life
Time frame: up to 1 year
Quality of life was assessed using the 36-item Short Form Health Survey (SF-36) scale. Completed responses for each of the 36 items were extracted from the database. Item responses were aggregated to calculate scores for each of the eight dimensions. Scores for each dimension range from 0 to 100, with higher scores indicating better health status
Time frame: up to 1 year
Anxiety and depression were evaluated using the Hospital Anxiety and Depression Scale (HADS). Completed responses for the 14-item HADS, comprising 7 items each for the anxiety (HADS-A) and depression (HADS-D) subscales, were extracted from the database. Item scores range from 0 to 3, and were summed to yield separate scores for anxiety and depression
Time frame: up to 1 year
Bone pain was evaluated using the Numerical Rating Scale (NRS). Completed NRS scores, ranging from 0 to 10, were extracted from the database. In this scale, 0 represents no pain, 1-3 represents mild pain, 4-6 represents moderate pain, 7-9 represents severe pain, and 10 represents the worst pain
Time frame: an average of 1 week
Contact information is provided by the study sponsor or research team.
West China Hospital
Other
Quality of Life Change in Patients Undergoing Parathyroidectomy With Secondary Hyperparathyroidism Due toEnd-stage Renal Failure: a Retrospective Cohort Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03588884
CKD Stage 3, CKD Stage 4
Garden Grove, California, United States
View Trial DetailsNCT04267965
Dysphonia, Laryngeal Diseases
Kaohsiung City, Taiwan
View Trial DetailsNCT01939977
Endocrine System Diseases, Hyperparathyroidism
Badalona, Barcelona, Spain
View Trial DetailsNCT01834755
Chronic Disease, Disease Attributes
Nice, France
View Trial Details